BillionToOne, Inc. financials

BLLN CIK 0002070849

Source: EDGAR filings · Built 2026-06-02T02:29:15Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2025FY 2025
Free Cash Flow 13.94M -49.15M -61.94M
EBITDA 22.92M -40.15M -63.59M
Working Capital 512.60M 199.43M
Net Debt -387.08M -82.10M
Gross Margin 68.32% 53.03% 24.13%
Operating Margin 5.25% -30.90% -96.89%
Net Margin 2.44% -27.24% -115.27%
Return on Equity (ROE) 1.55% 16.52% 37.75%
Return on Assets (ROA) 1.18% -13.76%
Current Ratio 11.69× 8.03×
Debt-to-Equity 0.23× -0.43×
Effective Tax Rate 3.93% -0.07% -0.01%
Cash Conversion Ratio 3.30× 1.00× 0.65×
Accruals Ratio -0.03× -0.00×
SBC % of Revenue 5.22% 5.48% 6.77%
CapEx Coverage 2.31× -5.32× -6.49×
Free Cash Flow Per Share $0.66 $-4.88 $-6.33

Valuation Metrics

Concept FY 2025FY 2025FY 2025
P/E Trailing (Diluted) 584.57×
P/FCF 124.66×
FCF Yield 0.80%
EV / EBITDA 58.91×
P/S 5.69×
P/B 3.62×

Income Statement

Concept FY 2025FY 2025FY 2025
Revenue from Contract with Customer, Excluding Assessed Tax 305.11M 152.58M 71.73M
Cost of Goods and Services Sold 96.65M 71.67M 54.42M
Gross Profit 208.46M 80.92M 17.31M
Research and Development Expense 49.38M 36.60M 22.41M
Selling, General and Administrative Expense 143.05M 91.47M 64.39M
Operating Expenses 192.44M 128.06M 86.80M
Operating Income (Loss) 16.02M -47.15M -69.50M
Income Tax Expense (Benefit) 305.00K 29.00K 9.00K
Net Income (Loss) Attributable to Parent 7.45M -41.57M -82.68M
Earnings Per Share, Basic $0.18 $-4.12 $-8.45
Weighted Average Number of Shares Outstanding, Basic 15.88M 10.08M 9.78M
Earnings Per Share, Diluted $0.14 $-4.12 $-8.45
Weighted Average Number of Shares Outstanding, Diluted 21.23M 10.08M 9.78M

Balance Sheet

Concept FY 2025FY 2025FY 2025
Cash and Cash Equivalents, at Carrying Value 495.98M 191.48M
Assets, Current 560.56M 227.82M
Assets 632.65M 302.06M
Long-term Debt 57.23M 51.48M
Liabilities, Current 47.96M 28.39M
Long-term Debt, Excluding Current Maturities 57.23M 51.48M
Liabilities 152.55M 134.31M
Stockholders' Equity Attributable to Parent 480.11M -251.66M -219.05M
Common Stock, Shares, Outstanding 10.93M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (BLLN CIK 0002070849), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

APD

AIR PRODUCTS AND CHEMICALS, INC.

GPC

GENUINE PARTS CO

PTCT

PTC Therapeutics, Inc.